Literature DB >> 11229650

Tibia metastasis without prostate specific antigen (PSA) increase following radical vesiculo-prostatectomy.

J Hübler1, F Sükösd, M Czipri.   

Abstract

OBJECTIVES: PSA is regarded as the best method in the follow-up of prostate carcinoma. After radical vesiculo-prostatectomy the prostate carcinoma seldom recurs at zero or nearly zero PSA levels.
METHODS: The authors have used PSA since 1989 and they have found only one case where metastasis in the tibia came without an increase in PSA levels.
RESULTS: Tibia metastasis showed lower tissue activity of PSA than did the primary tumor in the prostate. The authors think this explains the zero PSA level when the metastasis developed.
CONCLUSIONS: The authors think based on their case that PSA free progression prostate cacncers may cases where the metastases do not produce PSA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11229650     DOI: 10.1023/a:1007142910479

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  6 in total

1.  Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level.

Authors:  B D Leibman; O Dillioglugil; T M Wheeler; P T Scardino
Journal:  Cancer       Date:  1995-12-15       Impact factor: 6.860

2.  Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy.

Authors:  D E Goldrath; E M Messing
Journal:  J Urol       Date:  1989-10       Impact factor: 7.450

3.  Clinical use of prostate specific antigen in patients with prostate cancer.

Authors:  M A Hudson; R R Bahnson; W J Catalona
Journal:  J Urol       Date:  1989-10       Impact factor: 7.450

4.  Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.

Authors:  A W Partin; C R Pound; J Q Clemens; J I Epstein; P C Walsh
Journal:  Urol Clin North Am       Date:  1993-11       Impact factor: 2.241

5.  Recurrent prostate cancer despite undetectable prostate specific antigen.

Authors:  T K Takayama; J N Krieger; L D True; P H Lange
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

6.  Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer.

Authors:  M Aihara; R M Lebovitz; T M Wheeler; B M Kinner; M Ohori; P T Scardino
Journal:  J Urol       Date:  1994-06       Impact factor: 7.450

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.